The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab

SIMPLE SUMMARY: Identifying reliable prognostic biomarkers of progression in the early phases of treatment is crucial in patients undergoing immune checkpoints inhibitors (ICI) administration for advanced non-small cell lung cancer (NSCLC). With this aim, in this study we combined the prognostic pow...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauckneht, Matteo, Genova, Carlo, Rossi, Giovanni, Rijavec, Erika, Dal Bello, Maria Giovanna, Ferrarazzo, Giulia, Tagliamento, Marco, Donegani, Maria Isabella, Biello, Federica, Chiola, Silvia, Zullo, Lodovica, Raffa, Stefano, Lanfranchi, Francesco, Cittadini, Giuseppe, Marini, Cecilia, Lopci, Egesta, Sambuceti, Gianmario, Grossi, Francesco, Morbelli, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268031/
https://www.ncbi.nlm.nih.gov/pubmed/34206545
http://dx.doi.org/10.3390/cancers13133117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268031/
https://www.ncbi.nlm.nih.gov/pubmed/34206545
http://dx.doi.org/10.3390/cancers13133117

Ejemplares similares